Search Results - "Saw, P L"

PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancer by Saw, Stephanie P.L., Ng, Win Pin, Zhou, Siqin, Lai, Gillianne G.Y., Tan, Aaron C., Ang, Mei-Kim, Lim, Wan-Teck, Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Tan, Wan Ling, Rajasekaran, Tanujaa, Chan, Johan W.K., Teh, Yi Lin, Pang, Mengyuan, Yeo, Jia-Chi, Takano, Angela, Ong, Boon-Hean, Tan, Eng-Huat, Tan, Sze Huey, Skanderup, Anders J., Tan, Daniel S.W.

“…To determine the prognostic value of programmed death-ligand 1 (PD-L1) score in early-stage epidermal growth factor receptor (EGFR)-mutated non-small cell lung…”
Get full text

Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer by Saw, Stephanie P L, Zhou, Siqin, Chen, Jianbin, Lai, Gillianne, Ang, Mei-Kim, Chua, Kevin, Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Tan, Wan Ling, Rajasekaran, Tanujaa, Lim, Darren W T, Tan, Aaron, Fong, Kam Weng, Takano, Angela, Cheng, Xin Ming, Lim, Kiat Hon, Koh, Tina, Ong, Boon-Hean, Tan, Eng Huat, Toh, Chee Keong, Skanderup, Anders J, Tan, Sze Huey, Tan, Daniel S W

“…The recently published ADAURA study has posed a significant dilemma for clinicians in selecting patients for adjuvant osimertinib. Risk factors for recurrence…”
Get full text

Revisiting neoadjuvant therapy in non-small-cell lung cancer by Saw, Stephanie P L, Ong, Boon-Hean, Chua, Kevin L M, Takano, Angela, Tan, Daniel S W

“…Despite the rapidly evolving treatment landscape in advanced non-small-cell lung cancer (NSCLC), developments in neoadjuvant and adjuvant treatments have been…”
Get full text

MET alterations in NSCLC-Current Perspectives and Future Challenges by Remon, Jordi, Hendriks, Lizza E L, Mountzios, Giannis, García-Campelo, Rosario, Saw, Stephanie P L, Uprety, Dipesh, Recondo, Gonzalo, Villacampa, Guillermo, Reck, Martin

“…Targeted therapies have revolutionized the treatment and improved the outcome for oncogene-driven NSCLC and an increasing number of oncogenic driver therapies…”
Get more information

Anti-CTLA-4 in non-small-cell lung cancer: insights from the NIPPON study by Li, Molly S C, Saw, Stephanie P L, Addeo, Alfredo

Get full text

Co-targeting the VEGF axis and immune checkpoints in NSCLC: back to the future by Saw, S.P.L., Tan, D.S.W.

Get full text

Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage lung cancer by Tan, Aaron C., Lai, Gillianne G. Y., Saw, Stephanie P. L., Chua, Kevin L. M., Takano, Angela, Ong, Boon‐Hean, Koh, Tina P. T., Jain, Amit, Tan, Wan Ling, Ng, Quan Sing, Kanesvaran, Ravindran, Rajasekaran, Tanujaa, Kalashnikova, Ekaterina, Renner, Derrick, Sudhaman, Sumedha, Malhotra, Meenakshi, Sethi, Himanshu, Liu, Minetta C., Aleshin, Alexey, Lim, Wan‐Teck, Tan, Eng‐Huat, Skanderup, Anders J., Ang, Mei‐Kim, Tan, Daniel S. W.

“…Background In early‐stage non–small cell lung cancer (NSCLC), recurrence is frequently observed. Circulating tumor DNA (ctDNA) has emerged as a noninvasive…”
Get full text

Immunotherapy with chemotherapy and anti-angiogenic therapy for EGFR mutated NSCLC: challenging the dogma by Tan, Aaron C., Kobayashi, Keigo, Saw, Stephanie P.L., Tan, Daniel S.W., Lim, Darren Wan-Teck

Get full text

Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC by Saw, Stephanie P.L., Low, Yi Fen, Lai, Gillianne G.Y., Chan, Landon L., Wong, Wesley K.Y., Tsui, Giselle, Chen, Olivia H., Seet, Amanda O.L., Tan, Wei Chong, Tan, Aaron C., Chan, Johan W.K., Teh, Yi Lin, Tan, Wan-Ling, Ng, Quan Sing, Ang, Mei-Kim, Kanesvaran, Ravindran, Lim, Darren W.T., Tan, Daniel S.W., Mok, Tony S.K., Li, Molly S.C.

“…•Addition of pemetrexed-platinum on first-line osimertinib progression is effective.•Patients with L858R and baseline CNS metastases also benefit from this…”
Get full text

Resistance to Brevicoryne brassicae in horticultural brassicas by Ellis, P.R. (Horticulture Research International, Wellesbourne, Warwick (United Kingdom)), Singh, R, Pink, D.A.C, Lynn, J.R, Saw, P.L

“…A wide range of cultivated brassica accessions including broccoli, Brussels sprouts, Chinese cabbage, cauliflower, collard, kale and swede material was tested…”
Get full text

Adjuvant Immunotherapy in Patients with Early-Stage Non-small Cell Lung Cancer and Future Directions by Saw, Stephanie PL, Ang, Mei-Kim, Tan, Daniel SW

“…Opinion statement While cisplatin-based adjuvant chemotherapy has been the standard of care for the past two decades, the recent introduction of immunotherapy…”
Get full text

Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung Cancer by Tan, Aaron C, Saw, Stephanie P L, Chen, Jianbin, Lai, Gillianne G Y, Oo, Hlaing Nwe, Takano, Angela, Lau, Dawn P X, Yeong, Joe P S, Tan, Gek San, Lim, Kiat Hon, Skanderup, Anders J, Chan, Johan W K, Teh, Yi Lin, Rajasekaran, Tanujaa, Jain, Amit, Tan, Wan Ling, Ng, Quan Sing, Kanesvaran, Ravindran, Lim, Wan-Teck, Ang, Mei-Kim, Tan, Daniel S W

“…-altered non-small-cell lung cancer (NSCLC) represents a diverse subgroup, including mutations, amplifications, and overexpression. However, exon 20 insertion…”
Get more information

Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate Measure by Saw, Stephanie P L, Tan, Gek San, Tan, Wei Chong, Tan, Aaron C, Lai, Gillianne G Y, Lim, Darren W T, Kanesvaran, Ravindran, Tan, Wan Ling, Tan, Sze Huey, Lim, Kiat Hon, Skanderup, Anders J, Tan, Daniel S W

“…To compare the performance of droplet digital polymerase chain reaction (ddPCR) and plasma next-generation sequencing (NGS) in detecting clearance of plasma…”
Get full text

Identification of sources of resistance in lettuce to the lettuce root aphid, Pemphigus bursarius by Ellis, PR, McClement, S J, Saw, P L, Phelps, K, Vice, W E, Kift, N B, Astley, D, Pink DAC

“…In a series of glasshouse and laboratory experiments, lettuce varieties and wild Lactuca species were screened for resistance to the lettuce root aphid,…”
Get full text

Identification of sources of resistance in lettuce to the lettuce root aphid, Pemphigus bursarius: Resistance to lettuce root aphid by ELLIS, P. R, MCCLEMENT, S. J, SAW, P. L, PHELPS, K, VICE, W. E, KIFT, N. B, ASTLEY, D, PINK, D. A. C

Get full text

Trials without borders—decentralized trials and ensuring access to novel cancer therapies during a global pandemic by Tan, A.C., Tan, T.J.Y., Saw, S.P.L., Lam, J.Y.C., Yap, Y.S., Lim, W.-T., Tai, D.W.M., Ng, M.C.H., Tan, D.S.W.

Get full text

A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC by Lai, Gillianne G.Y., Yeo, Jia Chi, Jain, Amit, Zhou, Siqin, Pang, Mengyuan, Alvarez, Jacob J.S., Sim, Ngak Leng, Tan, Aaron C., Suteja, Lisda, Lim, Tze Wei, Guo, Yu Amanda, Shen, Meixin, Saw, Stephanie P.L., Rohatgi, Neha, Yeong, Joe P.S., Takano, Angela, Lim, Kiat Hon, Gogna, Apoorva, Too, Chow Wei, Da Zhuang, Kun, Tan, Wan Ling, Kanesvaran, Ravindran, Ng, Quan Sing, Ang, Mei Kim, Rajasekaran, Tanujaa, Wang, Lanying, Toh, Chee Keong, Lim, Wan-Teck, Tam, Wai Leong, Tan, Sze Huey, Skanderup, Anders M.J., Tan, Eng-Huat, Tan, Daniel S.W.

“…Although immune checkpoint inhibitors (ICIs) have dramatically improved outcomes for nononcogene-addicted NSCLC, monotherapy with programmed cell death…”
Get full text